XELLIA PHARMACEUTICALS ApS — Credit Rating and Financial Key Figures
CVR number: 61094628
Dalslandsgade 11, 2300 København S
tel: 32645500
Income statement (mDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | 2 043.00 | 1 622.00 | 2 245.00 | 1 986.82 | 1 599.38 |
| Costs of manufacturing | -2 626.27 | -1 562.37 | |||
| Gross profit | 2 043.00 | 1 622.00 | 2 245.00 | - 639.45 | 37.01 |
| Costs of management | - 247.83 | - 396.52 | |||
| Costs of distribution | -80.23 | -62.74 | |||
| Other operating expenses | - 219.52 | - 450.18 | |||
| EBIT | 2 043.00 | 1 622.00 | 2 245.00 | -1 187.04 | - 872.43 |
| Other financial income | 58.88 | 24.14 | |||
| Other financial expenses | -73.44 | - 207.16 | |||
| Net income from associates (fin.) | -1 440.14 | 1 211.06 | |||
| Pre-tax profit | - 116.00 | - 503.00 | - 371.00 | -2 641.74 | 684.36 |
| Income taxes | 256.84 | 144.61 | |||
| Net earnings | - 116.00 | - 503.00 | - 371.00 | -2 384.90 | 828.97 |
Assets (mDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Development expenditure | 36.23 | 16.88 | |||
| Intangible rights | 76.91 | 66.07 | |||
| Intangible assets total | 113.14 | 82.95 | |||
| Land and waters | 59.21 | 86.31 | |||
| Buildings | 232.34 | 226.33 | |||
| Machinery and equipment | 27.84 | 24.66 | |||
| Advance payments and construction in progress | 144.47 | 90.53 | |||
| Tangible assets total | 463.86 | 427.84 | |||
| Holdings in group member companies | 205.32 | 1 293.45 | |||
| Investments total | 4 091.00 | 3 734.00 | 3 460.00 | 205.32 | 1 293.45 |
| Long term receivables total | |||||
| Semifinished products | 215.22 | 156.92 | |||
| Raw materials and consumables | 74.75 | 75.47 | |||
| Finished products/goods | 283.06 | 258.83 | |||
| Inventories total | 573.03 | 491.22 | |||
| Current trade debtors | 199.65 | 272.79 | |||
| Current amounts owed by group member comp. | 256.99 | 496.73 | |||
| Prepayments and accrued income | 29.90 | 20.95 | |||
| Current other receivables | 124.59 | 33.17 | |||
| Current deferred tax assets | 138.25 | 81.06 | |||
| Short term receivables total | 749.39 | 904.70 | |||
| Cash and bank deposits | 0.25 | 0.32 | |||
| Cash and cash equivalents | 0.25 | 0.32 | |||
| Balance sheet total (assets) | 4 091.00 | 3 734.00 | 3 460.00 | 2 105.00 | 3 200.47 |
Equity and liabilities (mDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 2 621.00 | 2 083.00 | 1 751.00 | 201.00 | 201.00 |
| Other reserves | 4.87 | 3.38 | |||
| Other restricted equity | 28.25 | -40.48 | |||
| Retained earnings | 116.00 | 503.00 | 371.00 | 1 553.00 | - 830.41 |
| Profit of the financial year | - 116.00 | - 503.00 | - 371.00 | -2 384.90 | 828.97 |
| Shareholders equity total | 2 621.00 | 2 083.00 | 1 751.00 | - 597.77 | 162.45 |
| Provisions | 121.25 | 69.94 | |||
| Non-current loans from credit institutions | 150.51 | 128.26 | |||
| Non-current leasing loans | 1.31 | 0.68 | |||
| Non-current advances received | 42.18 | 42.97 | |||
| Non-current owed to group member | 313.63 | 344.92 | |||
| Non-current owed to participating | 14.24 | 31.72 | |||
| Non-current deferred tax liabilities | 16.39 | 19.99 | |||
| Non-current liabilities total | 538.26 | 568.54 | |||
| Current loans from credit institutions | 22.21 | 23.87 | |||
| Current trade creditors | 120.86 | 81.97 | |||
| Current owed to group member | 1 741.39 | 2 073.42 | |||
| Other non-interest bearing current liabilities | 158.81 | 220.27 | |||
| Current liabilities total | 2 043.27 | 2 399.53 | |||
| Balance sheet total (liabilities) | 2 621.00 | 2 083.00 | 1 751.00 | 2 105.00 | 3 200.47 |
CreditReports API
- Company information
- Financial data
- Credit risk data
- All 400,000+ Danish companies
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.